Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.
about
H5N1 viruses and vaccinesLive, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferretsPandemic Threat Posed by Avian Influenza A VirusesMultivalent HA DNA vaccination protects against highly pathogenic H5N1 avian influenza infection in chickens and miceCLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In VivoImmunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primatesAre we ready for pandemic influenza H5N1?Developing vaccines against pandemic influenzaImparting temperature sensitivity and attenuation in ferrets to A/Puerto Rico/8/34 influenza virus by transferring the genetic signature for temperature sensitivity from cold-adapted A/Ann Arbor/6/60.Influenza: lessons from past pandemics, warnings from current incidents.Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strainProtective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination.All-in-one bacmids: an efficient reverse genetics strategy for influenza A virus vaccines.A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets.Development of a vaccine against pandemic influenza viruses: current status and perspectives.Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge.Influenza vaccines based on virus-like particlesGeneration of candidate human influenza vaccine strains in cell culture - rehearsing the European response to an H7N1 pandemic threatImproving seasonal and pandemic influenza vaccinesMolecular pathogenesis of H5 highly pathogenic avian influenza: the role of the haemagglutinin cleavage site motifDesigning vaccines for pandemic influenza.Animal models for the preclinical evaluation of candidate influenza vaccines.Label-free, arrayed sensing of immune response to influenza antigens.A reassortment-incompetent live attenuated influenza virus vaccine for protection against pandemic virus strains.New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges.A step closer to meeting the threat of avian influenza.Attenuation of equine influenza viruses through truncations of the NS1 proteinAvian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammalsDose-response assessment for influenza A virus based on data sets of infection with its live attenuated reassortants.Pathogenesis of avian influenza A (H5N1) viruses in ferrets.Complex disease dynamics and the design of influenza vaccination programsEmerging respiratory viruses: challenges and vaccine strategiesThe complexity of human infected AIV H5N6 isolated from China.Evaluation of live attenuated influenza a virus h6 vaccines in mice and ferretsCharacterization of a trypsin-dependent avian influenza H5N1-pseudotyped HIV vector system for high throughput screening of inhibitory molecules.Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines.HIV-1 envelope glycoprotein stimulates viral transcription and increases the infectivity of the progeny virus through the manipulation of cellular machinery.Restrictions to the adaptation of influenza a virus h5 hemagglutinin to the human host.Performance of rapid tests for detection of avian influenza A virus types H5N1 and H9N2.H5N1 influenza virus-like particles produced by transient expression in mammalian cells induce humoral and cellular immune responses in mice.
P2860
Q21131612-FB61EEC8-D33A-4BE6-9B51-3FE3506E4DEAQ21563426-76484035-3C60-4F98-BC4A-EB4C1CAE71C3Q22299330-670BDD40-366B-4A51-A8D2-71CE642285F9Q27301043-E4F118C4-B832-4630-9C2C-F1D380830781Q28354040-44B52D3C-2D1D-4D6A-98BF-E9FD616C22B6Q28475369-19704687-8400-4CA9-95D2-F8F682A59CF0Q30233047-9508B310-787D-45F5-87CA-5E640CBEBD7AQ30329367-CE8662CE-7837-4C34-815A-5686D8BE9652Q30336518-43AA9E8E-013F-4C62-BBB1-81F0BBF97F6DQ30351160-B452D129-2CE5-4655-A18A-2189E78F76F1Q30351385-B6FE33F0-E88E-4AA6-ABDB-B480A130AD3CQ30357455-0094462C-2BA8-430C-A757-D60B49C86316Q30363730-5BE15FFB-ABD1-4723-ADC0-6D9DB804C76DQ30370303-4BCF884C-9827-4A4A-8210-78E7F128576EQ30373784-0DB7B96C-DBB6-4FBB-8E58-BE2AB6F2B65EQ30375784-D749E71C-5E27-4268-96E6-34D71598F410Q30376236-CCD17093-78ED-48BB-A2ED-79ABF9951952Q30376964-653C2D3C-B2F8-44B4-9B94-2E5821BE8145Q30377211-2B2C7A7E-7862-43F1-AE0A-F7CFC30746FEQ30380274-18A015BB-FB43-4481-BF85-F0A9B2900A8CQ30380889-B3624BFE-29A6-4046-994A-7D45A8306DF6Q30383623-4774DAE7-7ACB-4D95-B737-762DFC4E8064Q30397233-D64B87B3-ACE7-47AA-BA5C-D2D777F5BC38Q30402334-3D2FC1A0-43EA-4309-BA78-28C48AD12DA1Q30407424-E1628572-F22A-4A65-9239-3572E3A9E1B9Q33257256-53585E3C-1CA8-4A05-A944-21AFB9FD5D00Q33843410-F7CBF7DE-B0AC-4404-8730-6607ACC7E828Q33987458-385BD696-06BE-47B6-BE20-5ADED6689C36Q34041781-08A63902-3CFA-452D-977F-EAAB24037A00Q34999473-4EB79224-1341-49AA-BB88-4BF40452D74BQ35047980-A93A7AE0-625D-4CE8-8FC1-B5367105244FQ35070868-2AE570CB-ADD3-4559-AF19-15E88FFE2413Q36174682-CCFAB549-8372-4EA8-AE6D-BDD3E184CD52Q37033178-34469099-316C-4684-9920-DC0B7817EEDBQ37441922-A87EDD5D-E418-4C3B-9600-3140DCC62AF3Q39320921-47210D01-C9BE-42BD-BD2D-549C1B8FA3CEQ40069769-AC346BA4-CB0C-452A-ABD6-260DC9712E1CQ40377049-4BC2A765-8F32-416B-B824-0B916AC67BC8Q42913020-509B7455-1958-49F5-8A74-2A53545CAA13Q45358893-87E8C5BA-914F-4E44-992D-0B97D90AFF45
P2860
Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Recombinant influenza A virus ...... A/Hong Kong/97 (H5N1) viruses.
@en
type
label
Recombinant influenza A virus ...... A/Hong Kong/97 (H5N1) viruses.
@en
prefLabel
Recombinant influenza A virus ...... A/Hong Kong/97 (H5N1) viruses.
@en
P2093
P356
P1476
Recombinant influenza A virus ...... A/Hong Kong/97 (H5N1) viruses.
@en
P2093
P304
P356
10.1086/314713
P407
P577
1999-05-01T00:00:00Z